Indegene Limited has announced a strong performance in the first quarter of FY27, with revenue growth of 39.7% year-over-year, reaching ₹10,631 million. The company’s EBITDA margin stood at 16.9%, with a profit after tax of ₹1,162 million. This information is based on a BSE filing made by the company.
The company’s revenue per employee has further strengthened to $77.1K, the highest among peers. The number of active clients has crossed the 100-milestone, increasing by 14 sequentially to 105. The company has also seen an expansion in the number of customers in the $10M+ range, with 12 customers now generating more than $10 million in annual revenue each.
The company’s strongest first-quarter QoQ revenue growth in four years is a testament to its focus on developing and scaling differentiated products, solutions, and GenAI-powered technologies. The company is committed to advancing AI-driven life sciences commercialization and driving the next phase of its growth.
As part of its strategy, the company has been investing in strengthening its sales and go-to-market teams. This investment has paid off, with the company seeing a significant increase in its active client base. The company’s profitability has also improved in step with its growth, with a profit margin of 10.9%.
The company’s strong performance in Q1 FY27 reinforces its position as a leading player in the life sciences industry. With its focus on innovation and customer relationships, the company is well-positioned for continued growth and success.
Disclaimer: The information provided is for educational purposes only and does not constitute financial advice. We are not registered financial advisors. Please conduct your own research and consult a qualified advisor before making investment decisions. Any investment decisions you make based on this information are solely at your own risk.
